Nanobiotechnology holds a lot of promise and people have often speculated how it will impact the world of medicine. Unfortunately promising nanostructured systems so far have turned out to be extremely toxic to humans.
Now a group of researchers at the University of Michigan Nanotechnology Institute for Medicine and Biological Sciences have devised a multifunctional nanoparticle platform comprising nanoparticles synthesized within dendrimers equipped with targeting molecules and dyes. These dendrimer nanoparticle systems are able to seek out and specifically bind to cancer cells.
Xiangyang Shi, Suhe Wang, James R. Baker Jr., and their colleagues have designed dendrimer nanoparticle systems that are stable, water soluble, and biocompatible.
The researchers start out by synthesizing gold nanoparticles within amine-terminated dendrimers.
Next, dye molecules and a targeting molecule, folic acid, are attached to the ends of the dendrimers.
Finally, the remaining amine groups are acetylated to ensure that the complex particles do not bear any surface charges. This last step is especially important to ensure the biocompatibility of these systems and to prevent the nonspecific adhesion of other materials. Molecular dynamics simulations indicate that the folic acid attachments project out into the solvent and are readily available for binding to cells, whereas the dye molecules stay far removed from the metal nanoparticles and thus retain their bright fluorescence.
Many cancer cells, including those implicated in cancers of the ovary, kidney, uterus, testis, brain, colon, and lungs, tend to overexpress folic acid receptors. Owing to the folic acid attachments grafted onto the dendrimer nanoparticles, the dendrimer nanoparticles are seen to latch onto the cancer cells via these folic acid receptors. Since the dendrimer nanoparticles are also equipped with dye molecules, the high concentrations of nanoparticles accumulated in the cancer cells can be imaged by confocal microscopy, and indeed diseased cells can be easily told apart from healthy cells.
Further verification comes from electron microscopy experiments. The high contrast provided by the gold nanoparticles allows the determination of the specific sites in the cell machinery where the nanoparticles are attached. Shi pointed out that it should be possible to design dendrimer nanoparticles with other biological ligands such as proteins and antibodies to image and target various biological systems.
“Beyond imaging, it may also be possible to specifically target and destroy cancer cells that internalize the nanoparticles by applying laser heat that intensifies in the presence of gold nanoparticles”, said Wang. “Another possibility is the attachment of drug molecules to these dendrimer nanoparticle systems”, added Baker, “since this will allow the direct delivery of drugs to the target cells”.
The researchers are currently conducting further in vivo experiments to evaluate the suitability of this system for clinical applications.
Source: Dendrimer-Entrapped Gold Nanoparticles as a Platform, Xiangyang Shi, University of Michigan, Small 2007, 3, No. 7, 1245–1252, doi: 10.1002/smll.200700054